The Role of RASs /RVs in the Current Management of HCV
Overview
Affiliations
The approval of combination therapies with direct-acting antiviral (DAA) regimens has led to significant progress in the field of hepatitis C virus (HCV) treatment. Although most patients treated with these agents achieve a virological cure, resistance to DAAs is a major issue. The rapid emergence of resistance-associated substitutions (RASs), in particular in the context of incomplete drug pressure, has an impact on sustained virological response (SVR) rates. Several RASs in NS3, NS5A and NS5B have been linked with reduced susceptibility to DAAs. RAS vary based on HCV characteristics and the different drug classes. DAA-resistant HCV variant haplotypes (RVs) are dominant in cases of virological failure. Viruses with resistance to NS3-4A protease inhibitors are only detected in the peripheral blood in a time frame ranging from weeks to months following completion of treatment, whereas NS5A inhibitor-resistant viruses may persist for years. Novel agents have been developed that demonstrate promising results in DAA-experienced patients. The recent approval of broad-spectrum drug combinations with a high genetic barrier to resistance and antiviral potency may overcome the problem of resistance.
Mustafa A, Davlidova S, Abidi S, Begimbetova D, Heimer R, Vermund S BMJ Open Gastroenterol. 2025; 12(1).
PMID: 39848793 PMC: 11758705. DOI: 10.1136/bmjgast-2024-001657.
Fedorchenko S, Klimenko Z, Martynovich T, Solianyk I, Suprunenko T J Virol. 2025; 99(2):e0184324.
PMID: 39840947 PMC: 11852967. DOI: 10.1128/jvi.01843-24.
Sayad B, Bozorgomid A, Sayad N, Azhdari M, Bahadori M, Rezaeian S Health Sci Rep. 2024; 7(9):e70079.
PMID: 39314838 PMC: 11417008. DOI: 10.1002/hsr2.70079.
Khalil R, Al-Mahzoum K, Barakat M, Sallam M Pathogens. 2024; 13(8).
PMID: 39204274 PMC: 11356961. DOI: 10.3390/pathogens13080674.
Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.
Sallam M, Khalil R Microorganisms. 2024; 12(6).
PMID: 38930417 PMC: 11205832. DOI: 10.3390/microorganisms12061035.